Quarterly Results Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Net Sales
1,560.20
1,473.47
1,335.61
1,372.96
1,318.40
1,250.76
1,154.78
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,560.20
1,473.47
1,335.61
1,372.96
1,318.40
1,250.76
1,154.78
Raw Material Cost
912.66
910.42
913.77
853.12
854.52
823.79
742.45
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
9.71
9.50
11.41
6.68
6.15
5.74
5.45
Selling and Distribution Expenses
315.26
304.27
291.07
280.55
262.30
277.64
258.79
Other Expenses
-0.97
-0.95
-1.14
-0.67
-0.61
-0.57
-0.32
Total Expenditure (Excl Depreciation)
1,227.92
1,214.69
1,204.84
1,133.67
1,116.82
1,101.43
1,003.44
Operating Profit (PBDIT) excl Other Income
332.29999999999995
258.8
130.8
239.3
201.6
149.3
151.3
Other Income
7.25
5.70
10.20
6.11
5.77
7.20
4.67
Operating Profit (PBDIT)
486.10
411.30
290.82
391.04
347.21
291.85
283.25
Interest
9.71
9.50
11.41
6.68
6.15
5.74
5.45
Exceptional Items
1.84
3.11
0.00
0.00
0.00
0.00
4.06
Gross Profit (PBDT)
647.53
563.05
421.84
519.84
463.88
426.97
412.33
Depreciation
146.58
146.82
149.86
145.64
139.86
135.32
127.24
Profit Before Tax
331.64
258.09
129.55
238.72
201.20
150.79
154.62
Tax
98.66
77.80
17.78
72.35
61.39
47.77
38.02
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
232.98
180.29
111.78
166.37
139.81
103.03
116.61
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
232.98
180.29
111.78
166.37
139.81
103.03
116.61
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
232.98
180.29
111.78
166.37
139.81
103.03
116.61
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
4,461.04
4,227.86
4,148.53
4,037.00
3,870.69
3,736.68
3,811.42
Earnings per share (EPS)
18.03
13.95
8.65
12.86
10.81
7.85
8.45
Diluted Earnings per share
18.03
13.95
8.65
12.86
10.81
7.85
8.45
Operating Profit Margin (Excl OI)
21.3%
17.56%
9.79%
17.43%
15.29%
11.94%
13.11%
Gross Profit Margin
30.65%
27.48%
20.92%
27.99%
25.87%
22.87%
24.41%
PAT Margin
14.93%
12.24%
8.37%
12.12%
10.6%
8.24%
10.1%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Sep 2025 is 18.34% vs 27.95% in Sep 2024
Consolidate Net Profit
YoY Growth in quarter ended Sep 2025 is 66.67% vs 75.41% in Sep 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Sep 2025 is 40.28% vs 42.25% in Sep 2024
Interest
YoY Growth in quarter ended Sep 2025 is 59.02% vs 10.91% in Sep 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Sep 2025 has improved from Sep 2024
Compare Quarterly Results Of Japan Animal Referral Medical Center Co., Ltd. With
Figures in Million
Consolidate Quarterly Results
Change(JPY)
Change(%)
Net Sales
1,560.20
11,514.00
-9,953.80
-86.45%
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,560.20
11,514.00
-9,953.80
-86.45%
Raw Material Cost
912.66
10,560.00
-9,647.34
-91.36%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
9.71
17.00
-7.29
-42.88%
Selling and Distribution Expenses
315.26
679.00
-363.74
-53.57%
Other Expenses
-0.97
-1.70
0.73
42.94%
Total Expenditure (Excl Depreciation)
1,227.92
11,239.00
-10,011.08
-89.07%
Operating Profit (PBDIT) excl Other Income
332.27
275.00
57.27
20.83%
Other Income
7.25
45.00
-37.75
-83.89%
Operating Profit (PBDIT)
486.10
439.00
47.10
10.73%
Interest
9.71
17.00
-7.29
-42.88%
Exceptional Items
1.84
0.00
1.84
Gross Profit (PBDT)
647.53
954.00
-306.47
-32.12%
Depreciation
146.58
119.00
27.58
23.18%
Profit Before Tax
331.64
301.00
30.64
10.18%
Tax
98.66
87.00
11.66
13.40%
Provisions and contingencies
0
0
0.00
Profit After Tax
232.98
214.00
18.98
8.87%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
232.98
214.00
18.98
8.87%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
232.98
214.00
18.98
8.87%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
4,461.04
18,453.00
-13,991.96
-75.82%
Earnings per share (EPS)
18.03
11.82
6.21
52.54%
Diluted Earnings per share
18.03
11.82
6.21
52.54%
Operating Profit Margin (Excl OI)
21.30%
2.39%
0.00
18.91%
Gross Profit Margin
30.65%
3.65%
0.00
27.00%
PAT Margin
14.93%
1.86%
0.00
13.07%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 156.02 Million
in Sep 2025Figures in Million
QoQ Growth in quarter ended Sep 2025 is 5.88% vs 10.32% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 18.34% vs 27.95% in Sep 2024
Quarterly - Consolidate Net Profit
Consolidate Net Profit 23.30 Million
in Sep 2025Figures in Million
QoQ Growth in quarter ended Sep 2025 is 29.23% vs 61.27% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 66.67% vs 75.41% in Sep 2024
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 47.89 Million
in Sep 2025Figures in Million
QoQ Growth in quarter ended Sep 2025 is 18.07% vs 44.55% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 40.28% vs 42.25% in Sep 2024
Quarterly - Interest
Interest 0.97 Million
in Sep 2025Figures in Million
QoQ Growth in quarter ended Sep 2025 is 2.11% vs -16.67% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 59.02% vs 10.91% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 21.30%
in Sep 2025Figures in %
QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025
YoY Growth in quarter ended Sep 2025 has improved from Sep 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
